¼¼°èÀÇ ¸¶Ãë, È£Èí, ¼ö¸é¿ä¹ý(ARS) ±â±â ½ÃÀå : ±Ô¸ð, Á¡À¯À², COVID-19 ¿µÇ⠺м®(2024-2030³â) : MedSuite
Anesthesia, Respiratory & Sleep Therapy Devices Market Size, Share & COVID19 Impact Analysis | Global | 2024-2030 | MedSuite | Includes: Anesthesia Devices, Respiratory Devices & Sleep Management Devices
»óǰÄÚµå : 1469303
¸®¼­Ä¡»ç : iData Research Inc.
¹ßÇàÀÏ : 2024³â 04¿ù
ÆäÀÌÁö Á¤º¸ : ¿µ¹® 554 Pages
 ¶óÀ̼±½º & °¡°Ý (ºÎ°¡¼¼ º°µµ)
US $ 9,995 £Ü 13,846,000
PDF (Single User License) help
PDF º¸°í¼­¸¦ 1¸í¸¸ ÀÌ¿ëÇÒ ¼ö ÀÖ´Â ¶óÀ̼±½ºÀÔ´Ï´Ù. Àμ⠺Ұ¡´ÉÇϸç Àμ⹰ÀÇ ÀÌ¿ë ¹üÀ§´Â PDF ÀÌ¿ë ¹üÀ§¿Í µ¿ÀÏÇÕ´Ï´Ù.
US $ 11,995 £Ü 16,616,000
PDF (Site License) help
PDF º¸°í¼­¸¦ µ¿ÀÏ »ç¾÷ÀåÀÇ ¸ðµç ºÐÀÌ ÀÌ¿ëÇÒ ¼ö ÀÖ´Â ¶óÀ̼±½ºÀÔ´Ï´Ù. Àμâ´Â °¡´ÉÇϸç Àμ⹰ÀÇ ÀÌ¿ë ¹üÀ§´Â PDF ÀÌ¿ë ¹üÀ§¿Í µ¿ÀÏÇÕ´Ï´Ù.
US $ 13,995 £Ü 19,387,000
PDF (Corporate License) help
PDF º¸°í¼­¸¦ µ¿ÀÏ ±â¾÷(ÇØ¿Ü)ÀÇ ¸ðµç ºÐÀÌ ÀÌ¿ëÇÒ ¼ö ÀÖ´Â ¶óÀ̼±½ºÀÔ´Ï´Ù. Àμâ´Â °¡´ÉÇϸç Àμ⹰ÀÇ ÀÌ¿ë ¹üÀ§´Â PDF ÀÌ¿ë ¹üÀ§¿Í µ¿ÀÏÇÕ´Ï´Ù.


Çѱ۸ñÂ÷

¼¼°èÀÇ ¸¶Ãë, È£Èí, ¼ö¸é¿ä¹ý(ARS) ±â±â ½ÃÀå ±Ô¸ð´Â 2023³â 109¾ï ´Þ·¯¿¡ ´ÞÇß½À´Ï´Ù. ÀÌ ½ÃÀåÀº ¿¹Ãø ±â°£ µ¿¾È 4.5%ÀÇ CAGR·Î ¼ºÀåÇÏ¿© 148¾ï ´Þ·¯¿¡ ´ÞÇÒ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù.

¼¼°è ARS ½ÃÀåÀº ÇöÀç Àα¸ Åë°èÇÐÀû ¿äÀÎÀ» ÁÖ¿ä ¿äÀÎÀ¸·Î ÇÏ¿© Å« ¼ºÀå¼¼¸¦ º¸À̰í ÀÖ½À´Ï´Ù. ÁÖ¿ä ¿äÀÎ Áß Çϳª´Â °í·ÉÈ­À̸ç, ÀÌ´Â Àü ¼¼°è ´ëºÎºÐÀÇ Áö¿ª¿¡¼­ Á¡Á¡ ´õ ¿ì¼¼ÇØÁö°í ÀÖ½À´Ï´Ù. ÀÌ·¯ÇÑ Àα¸ Åë°è ÇÐÀû º¯È­´Â ³ëÈ­¿¡ µû¸¥ ¼ö¼ú Áõ°¡, È£Èí±â ÁúȯÀÇ Áõ°¡, ¼ö¸é ¹«È£ÈíÁõ ÁõÈıºÀÇ À¯º´·ü Áõ°¡·Î À̾îÁý´Ï´Ù. ¶ÇÇÑ, ƯÈ÷ ºÏ¹Ì, Áßµ¿, È£ÁÖ, ´ºÁú·£µå µîÀÇ Áö¿ª¿¡¼­´Â Àü ¼¼°è ºñ¸¸À²ÀÇ Áõ°¡°¡ Å©°Ô ±â¿©Çϰí ÀÖ½À´Ï´Ù. ºñ¸¸Àº È£Èí±â Áúȯ ¹× ¼ö¸é Àå¾Ö¿Í ¹ÐÁ¢ÇÑ °ü·ÃÀÌ ÀÖÀ¸¸ç, üÁß °ü·Ã ¼ö¼úµµ Áõ°¡Çϰí ÀÖ½À´Ï´Ù.

2022³â ¼¼°è ÀÎÇ÷¹À̼ÇÀ²ÀÌ Å©°Ô »ó½ÂÇÏ¿© Áö³­ 30³â µ¿¾È °¡Àå ³ôÀº »ó½Â·üÀ» ±â·ÏÇß½À´Ï´Ù. ÀÌ·¯ÇÑ ÀÎÇ÷¹ÀÌ¼Ç Ãß¼¼´Â ´Ù¾çÇÑ »ê¾÷¿¡¼­ »ý»ê ºñ¿ëÀÇ »ó½ÂÀ» ÃÊ·¡ÇÏ¿© ÆÇ¸Å °¡°ÝÀ» »ó½Â½ÃÄ×À¸¸ç, ARS ½ÃÀå¿¡¼­´Â ´Ü¼ø ±â±â¿¡ ºñÇØ º¹ÀâÇÑ ±â±âÀÇ ºñ¿ë »ó½ÂÀÌ µÎµå·¯Á³½À´Ï´Ù. ÀÌ·¯ÇÑ °¡°Ý ÀλóÀÇ ¿µÇâÀº ´Ù¾çÇÑ ºÐ¾ß¿¡ ¿µÇâÀ» ¹ÌÃÆÀ¸³ª, ¼ÒºñÀÚÀÇ ¼ö¿ë ż¼°¡ °­È­µÈ °á°ú ÆÇ¸Å·®Àº À¯ÁöµÇ¾î ½ÃÀå ¼ºÀåÀ» °ßÀÎÇϰí ÀÖ½À´Ï´Ù. ÇâÈÄ ¿µÇâÀ» ¹Þ´Â ½ÃÀå¿¡¼­´Â ¼Óµµ°¡ ´À·ÁÁö°ÚÁö¸¸, °¡°Ý »ó½Â¼¼´Â Áö¼ÓµÉ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù.

¼¼°è ¸¶Ãë, È£Èí, ¼ö¸é¿ä¹ý(ARS) ±â±â ½ÃÀå¿¡ ´ëÇØ Á¶»çÇßÀ¸¸ç, ½ÃÀå °³¿ä¿Í ÇÔ²² ºÎ¹®º° µ¿Çâ, COVID-19ÀÇ ¿µÇ⠺м®, ½ÃÀå ÃËÁø¿äÀÎ ¹× ¾ïÁ¦¿äÀÎ, °æÀï»ç ½ÃÀå Á¡À¯À² ºÐ¼®, ½ÃÀå ÁøÃâ ±â¾÷ °³¿ä µîÀÇ Á¤º¸¸¦ ÀüÇØµå¸³´Ï´Ù.

¸ñÂ÷

ÁÖ¿ä ¿ä¾à

Á¶»ç ¹æ¹ý

¼¼°èÀÇ ¸¶Ãë, È£Èí, ¼ö¸é¿ä¹ý(ARS) ±â±â ½ÃÀå¿¡ ´ëÇÑ COVID-19ÀÇ ¿µÇâ

Áúȯ °³¿ä

Á¦Ç° Æò°¡

¼¼°èÀÇ ¸¶Ãë, È£Èí, ¼ö¸é¿ä¹ý(ARS) ±â±â ½ÃÀå °³¿ä

¸¶Ãë Àü´Þ À¯´Ö ½ÃÀå

¸¶Ãë ¸ð´ÏÅÍ ½ÃÀå

¸¶Ãë¿ë ÀÏȸ¿ë Á¦Ç° ½ÃÀå

ÀΰøÈ£Èí±â ½ÃÀå

³×ºí¶óÀÌÀú ½ÃÀå

È£Èí±â ÀÏȸ¿ë Á¦Ç° ½ÃÀå

»ê¼Ò¹ß»ý±â ½ÃÀå

Æó¼â¼º ¼ö¸é¹«È£ÈíÁõ Ä¡·á ±â±â ½ÃÀå

¼ö¸é Áø´Ü ±â±â ½ÃÀå

¾à¾î

ksm
¿µ¹® ¸ñÂ÷

¿µ¹®¸ñÂ÷

The Global Anesthesia, Respiratory & Sleep Therapy (ARS) Market reached a value of $10.9 billion in 2023 and is projected to grow at a CAGR of 4.5% during the forecast period, reaching $14.8 billion.

The comprehensive report suite covering the global ARS market includes anesthesia delivery units, anesthesia monitors, anesthesia disposables, ventilators, nebulizers, respiratory disposables, oxygen concentrators, therapeutic obstructive sleep apnea devices, and sleep diagnostics devices.

DATA TYPES INCLUDED

Unit Sales, Average Selling Prices, Market Value & Growth Trends

Forecasts Until 2030, and Historical Data to 2020

Market Drivers & Limiters for Each Segment

Competitive Analysis with Market Shares for Each Segment

Recent Mergers & Acquisitions

COVID19 Impact

Disease Overviews and Demographic Information

Company Profiles, Product Portfolios and SWOT for Top Competitors

Global Anesthesia, Respiratory, and Sleep Therapy Market Insights

The global ARS market is experiencing significant growth, largely driven by current demographic trends. One of the key factors is the aging population, which is becoming increasingly predominant across most regions worldwide. This demographic shift leads to a rise in age-related surgeries, respiratory ailments, and a higher prevalence of sleep apnea cases. Additionally, the escalating obesity rates globally contribute significantly, particularly in regions like North America, the Middle East, Australia, and New Zealand. Obesity is closely linked to respiratory and sleep disorders, as well as an increase in weight-related surgeries.

In 2022, the global inflation rate saw a substantial surge, marking the highest increase in over 30 years. This inflationary trend led to heightened production costs across various industries, subsequently driving up selling prices. Within the ARS market, this translated into more pronounced cost hikes for complex devices compared to simpler ones. Despite these price increases affecting multiple sectors, consumers have shown greater acceptance, resulting in sustained unit sales and bolstering market growth. Moving forward, prices are anticipated to continue their upward trajectory, albeit at a slower pace in the affected markets.

Global Anesthesia, Respiratory, and Sleep Therapy Market Share Insights

In 2023, ResMed emerged as the frontrunner in the global anesthesia, respiratory, and sleep management device market, largely propelled by its substantial dominance in the therapeutic obstructive sleep apnea sector, which stands as the largest market within ARS. Moreover, ResMed's primary competitor, Philips, has grappled with product recalls in recent years, further widening ResMed's lead in the market. ResMed also maintains a presence in the ventilator and sleep diagnostics segments.

Despite experiencing a slight decline in share within the therapeutic obstructive sleep apnea market, Philips Healthcare has managed to retain its overall market position by excelling in the anesthesia monitor, ventilator, oxygen concentrator, and sleep diagnostics device markets. Philips holds the second-largest share in the total ARS market, significantly surpassing the third-leading company.

Teleflex holds the third-leading position in the total ARS market, mainly due to its dominant role in the disposables markets, leading both the anesthesia and respiratory disposables segments. With anticipated growth in these segments, Teleflex is poised to maintain its leadership position in the ARS market.

Market Segmentation Summary

Anesthesia Delivery Units Market - Segmented By:

Setting Type: Hospital (High-Complexity, Low-Complexity), ASC

Anesthesia Monitors Market

Anesthesia Disposables Market - Segmented By:

Device Type: Anesthesia Circuit, Anesthesia Mask, Endotracheal Tube, Laryngeal Mask (Disposable, Reusable)

Ventilator Market - Segmented By:

Device Type: Acute Care, Sub-Acute Care, Home Care, Neonatal, Non-Invasive

Nebulizer Market - Segmented By:

Device Type: Compressor/Jet Nebulizer (Stationary, Portable), Ultrasonic Nebulizer, Vibrating Mesh Nebulizer

Respiratory Disposable Devices Market - Segmented By:

Device Type: Oxygen Cannula, Oxygen Mask, Tracheostomy Tube, Resuscitator, Heat and Moisture Exchanger (HME/HMEF)

Oxygen Therapy Devices Market - Segmented By:

Device Type: Oxygen Concentrator (Stationary, Portable)

Therapeutic Obstructive Sleep Apnea Devices Market - Segmented By:

Device Type: Positive Airway Pressure (Continuous, Auto-Titrating, Bi-Level), Sleep Therapy Interface (Nasal Mask, Full-Face Mask, Nasal Pillow/Alternative Interface)

Sleep Diagnostic Devices Market - Segmented By:

Device Type: Polysomnography, Home Respiratory Polygraphy

Research Scope Summary

Regions: North America(Canada, United States), Latin America (Argentina, Bolivia, Brazil, Chile, Colombia, Costa Rica, Dominican Republic, Ecuador, Guatemala, Mexico, Panama, Paraguay, Peru, Puerto Rico, Uruguay, Venezuela), Western Europe(Austria, Benelux, France, Germany, Italy, Portugal, Scandinavia, Spain, Switzerland, U.K.), Central & Eastern Europe (Azerbaijan, Baltic States, Belarus, Bulgaria, Croatia, Czech Republic, Georgia, Greece, Hungary, Kazakhstan, Poland, Romania, Russia, Serbia, Slovakia, Slovenia, Turkey, Ukraine), Middle East(Bahrain, Iran, Israel, Kuwait, Oman, Qatar, Saudi Arabia, United Arab Emirates), Asia Pacific (Australia, Cambodia, China, Hong Kong, India, Indonesia, Japan, Kyrgyzstan, Macao, Mongolia, Malaysia, Myanmar, New Zealand, Philippines, Pakistan, Singapore, South Korea, Taiwan, Thailand, Uzbekistan, Vietnam), Africa (Algeria, Egypt, Ethiopia, Ghana, Kenya, Libya, Morocco, Nigeria, South Africa, Sudan, Uganda)

Base Year: 2023

Forecast: 2024-2030

Historical Data: 2020-2023

Quantitative Coverage: Market Size, Market Shares, Market Forecasts, Market Growth Rates, Units Sold, and Average Selling Prices.

Qualitative Coverage: COVID19 Impact, Market Growth Trends, Market Limiters, Competitive Analysis & SWOT for Top Competitors, Mergers & Acquisitions, Company Profiles, Product Portfolios, FDA Recalls, Disruptive Technologies, Disease Overviews.

Data Sources: Primary Interviews with Industry Leaders, Government Physician Data, Regulatory Data, Hospital Private Data, Import & Export Data, iData Research Internal Database.

TABLE OF CONTENT

TABLE of CONTENTS

TABLE of CONTENTSi

List of Figuresxii

List of Chartsxxix

executive summary1

Global Anesthesia, Respiratory and Sleep Management Device Market Overview1

Competitive Analysis4

Market Trends8

Market Developments10

Markets Included13

Regions Included15

Version History17

research methodology18

impact of covid-19 on THE global Anesthesia, Respiratory, and Sleep Management Market32

Disease Overview44

Product Assessment48

Global Anesthesia, Respiratory and Sleep Management Device Market Overview137

Anesthesia Delivery Unit Market187

Anesthesia Monitor Market225

Anesthesia Disposables Market243

Ventilator Market294

Nebulizer Market346

Respiratory Disposables Market397

Oxygen Concentrator Market442

Therapeutic Obstructive Sleep Apnea Device Market476

Sleep Diagnostics Device Market533

Abbreviations566

(ÁÖ)±Û·Î¹úÀÎÆ÷¸ÞÀÌ¼Ç 02-2025-2992 kr-info@giikorea.co.kr
¨Ï Copyright Global Information, Inc. All rights reserved.
PC¹öÀü º¸±â